Effect of diabetes mellitus and blood sugar status on treatment outcome of tuberculosis patients

YOU Nan-nan; LU Wei; ZHU Li-mei; LIU Qiao

doi:10.16462/j.cnki.zhjbkz.2020.01.018

Volume 24 Issue 1

Mar. 2020

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2020 > 24(1): 90-96

YOU Nan-nan, LU Wei, ZHU Li-mei, LIU Qiao. Effect of diabetes mellitus and blood sugar status on treatment outcome of tuberculosis patients[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(1): 90-96. doi: 10.16462/j.cnki.zhjbkz.2020.01.018

Citation:

YOU Nan-nan, LU Wei, ZHU Li-mei, LIU Qiao. Effect of diabetes mellitus and blood sugar status on treatment outcome of tuberculosis patients[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(1): 90-96. doi: 10.16462/j.cnki.zhjbkz.2020.01.018

Citation:

PDF( 890 KB)

Effect of diabetes mellitus and blood sugar status on treatment outcome of tuberculosis patients

doi: 10.16462/j.cnki.zhjbkz.2020.01.018

YOU Nan-nan^{1, 2},
LU Wei¹,
ZHU Li-mei¹,
LIU Qiao^{1, 3
,
,}

1.
Chronic Infectious Disease Prevention and Control Institute, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China
2.
Department of Epidemiology and Biostatistics, School of Public Healthy Southeast University, Nanjing 210009, China
3.
Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 210009, China

Funds: National Science and Technology Major Project(2018ZX10715002); "Six One Project" Top-notch Talent Research Project(LGY2017083); Postgraduate Research & Practice Innovation Program of Jiangsu Province(KYCX19-1131)

More Information

Corresponding author: LIU Qiao, E-mail:liuqiaonjmu@163.com
Received Date: 2019-06-19
Rev Recd Date: 2019-09-30
Publish Date: 2020-01-10

Abstract

Abstract

Diabetes mellitus patients are at high risk of tuberculosis, and tuberculosis is one of the important reasons for inducing and aggravating acute complications of diabetes. At present, China is facing a serious dual epidemic of tuberculosis and diabetes, which has caused great harm to the health of our people, but also brought great burden to our social economy. In this paper, PubMed, Web of Science, CNKI and Wanfang data knowledge service platform were used to search the relevant literature. Research progress on the epidemiology of tuberculosis patients complicated with diabetes, the effect of diabetes and blood glucose on the treatment outcome of tuberculosis patients, and the mechanism of diabetes affecting the treatment outcome of tuberculosis patients were analyzed and summarized, and some references were provided for the treatment and management of tuberculosis patients in China in the future.
- Tuberculosis,
- Diabetes mellitus,
- Glycemic control,
- Hyperglycemia,
- Treatment outcomes

FullText(HTML)

References(58)

References

[1]	World Health Organization. Global tuberculosis report 2018[R]. Geneva, 2018.
[2]	International Diabetes Federation. IDF diabetes atlas[M]. Belgium: International Diabetes Federation, 2017.
[3]	Ma Y, Huang ML, Li T, et al. Role of diabetes mellitus on treatment effects in drug-susceptible initial pulmonary tuberculosis patients in China[J]. Biomed Environ Sci, 2017, 30(9): 671-675. DOI: 10.3967/bes2017.089.
[4]	GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the global burden of disease study 2015[J]. The Lancet Infectious Diseases, 2018, 18(3): 261-284. DOI: 10.1016/S1473-3099(17)30703-X.
[5]	Lee PH, Fu H, Lee MR, et al. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries[J]. Int J Tuberc Lung Dis, 2018, 22(1): 7-16. DOI: 10.5588/ijtld.17.0329.
[6]	Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies[J]. PLoS Med, 2008, 5(7): e152. DOI: 10.1371/journal.pmed.0050152.
[7]	Goldhaber-Fiebert JD, Jeon CY, Cohen T, et al. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants[J]. Int J Epidemiol, 2011, 40(2): 417-428. DOI: 10.1093/ije/dyq238.
[8]	要玉霞, 郭慧明.老年糖尿病合并肺结核患者治疗情况的回顾性调查[J].山东医药, 2012, 52(33): 70-71. Yao YX, Guo HM. A retrospective study on the treatment of elderly patients with diabetes mellitus and tuberculosis[J]. Shandong Med J, 2012, 52(33): 70-71.
[9]	Delgado-Sanchez G, Garcia-Garcia L, Castellanos-Joya M, et al. Association of pulmonary tuberculosis and diabetes in mexico: analysis of the national tuberculosis registry 2000-2012[J]. PLoS One, 2015, 10(6): e0129312. DOI: 10.1371/journal.pone.0129312.
[10]	毛晓辉, 王勃, 曹思哲.糖尿病合并肺结核的流行病学及诊治现状[J].临床肺科杂志, 2016, 21(12): 2300-2302. DOI: 10.3969/j.issn.1009-6663.2016.12.048. Mao XH, Wang B, Cao SZ. Epidemiology, diagnosis and treatment of diabetes mellitus with pulmonary tuberculosis[J]. J Clin Pulmonary Med, 2016, 21(12): 2300-2302. DOI: 10.3969/j.issn.1009-6663.2016.12.048.
[11]	Lin Y, Li L, Mi FL, et al. Screening patients with diabetes mellitus for tuberculosis in China[J]. Trop Med Int Health, 2012, 17(10): 1302-1308. DOI: 10.1111/j.1365-3156.2012.03069.x.
[12]	J⌀rgensen ME, Faurholt-Jepsen D. Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis?a systematic review[J]. Curr Diab Rep, 2014, 14(7): 505. DOI: 10.1007/s11892-014-0505-1.
[13]	Restrepo BI, Camerlin AJ, Rahbar MH, et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases[J]. Bull World Health Organ, 2011, 89(5): 352-359. DOI: 10.2471/BLT.10.085738.
[14]	Baker MA, Lin HH, Chang HY, et al. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study[J]. Clin Infect Dis, 2012, 54(6): 818-825. DOI: 10.1093/cid/cir939.
[15]	朱红, 王建华. 2型糖尿病并发肺结核病的危险因素探讨[J].中华流行病学杂志, 2006, 27(1): 58-62. DOI: 10.3760/j.issn:0254-6450.2006.01.016. Zhu H, Wang JH. Risk factors for the development of pulmonary tuberculosis among type 2 diabetes mellitus patients[J]. Chin J Epidemiol, 2006, 27(1): 58-62. DOI: 10.3760/j.issn:0254-6450.2006.01.016.
[16]	Bailey SL, Ayles H, Beyers N, et al. The association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study[J]. BMC Infect Dis, 2016, 16(1): 733. DOI: 10.1186/s12879-016-2066-1.
[17]	Martinez L, Zhu L, Castellanos ME, et al. Glycemic control and the prevalence of tuberculosis infection: a population-based observational study[J]. Clin Infect Dis, 2017, 65(12): 2060-2068. DOI: 10.1093/cid/cix632.
[18]	Yoon YS, Jung JW, Jeon EJ, et al. The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study[J]. Thorax, 2017, 72(3): 263-270. DOI: 10.1136/thoraxjnl-2015-207686.
[19]	Faurholt-Jepsen D, Range N, Praygod G, et al. The role of diabetes on the clinical manifestations of pulmonary tuberculosis[J]. Trop Med Int Health, 2012, 17(7): 877-883. DOI: 10.1111/j.1365-3156.2012.03002.x.
[20]	Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis[J]. Clin Infect Dis, 2007, 45(4): 428-435. DOI: 10.1086/519841.
[21]	Restrepo BI, Fisher-Hoch SP, Crespo JG, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population[J]. Epidemiol Infect, 2007, 135(3): 483-491. DOI: 10.1017/S0950268806006935.
[22]	Nandakumar KV, Duraisamy K, Balakrishnan S, et al. Outcome of tuberculosis treatment in patients with diabetes mellitus treated in the revised national tuberculosis control programme in Malappuram District, Kerala, India[J]. PLoS One, 2013, 8(10): e76275. DOI: 10.1371/journal.pone.0076275.
[23]	Chang JT, Dou HY, Yen CL, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance[J]. J Formos Med Assoc, 2011, 110(6): 372-381. DOI: 10.1016/S0929-6646(11)60055-7.
[24]	Faurholt-Jepsen D, Range N, PrayGod G, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania[J]. Trop Med Int Health, 2013, 18(7): 822-829. DOI: 10.1111/tmi.12120.
[25]	Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes[J]. Thorax, 2013, 68(3): 214-220. DOI: 10.1136/thoraxjnl-2012-201756.
[26]	Syed SSA, Ishaq ADM, Mohamed AJ, et al. Role of diabetes in the prognosis and therapeutic outcome of tuberculosis[J]. Int J Endocrinol., 2012, 2012: 645362. DOI: 10.1155/2012/645362.
[27]	Hongguang C, Min L, Shiwen J, et al. Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing[J]. Epidemiol Infect, 2015, 143(1): 150-156. DOI: 10.1017/S095026881400079X.
[28]	Mukhtar F, Butt ZA. Cohort profile: the diabetes-tuberculosis treatment outcome(DITTO)study in Pakistan[J]. BMJ Open, 2016, 6(12): e012970. DOI: 10.1136/bmjopen-2016-012970.
[29]	Siddiqui AN, Khayyam KU, Sharma M. Effect of diabetes mellitus on tuberculosis treatment outcome and adverse reactions in patients receiving directly observed treatment strategy in India: a prospective study[J]. Biomed Res Int, 2016. DOI: 10.1155/2016/7273935.
[30]	Dooley KE, Tang T, Golub JE, et al. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis[J]. Am J Trop Med Hyg, 2009, 80(4): 634-639. doi: 10.4269/ajtmh.2009.80.634
[31]	Tatar D, Senol G, Alpteki NS, et al. Tuberculosis in diabetics: features in an endemic area[J]. Jpn J Infect Dis, 2009, 62(6): 423-427.
[32]	Kang YA, Kim SY, Jo KW, et al. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis[J]. Respiration, 2013, 86(6): 472-478. DOI: 10.1159/000348374.
[33]	Fielder JF, Chaulk CP, Dalvi M, et al. A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates[J]. Int J Tuberc Lung Dis, 2002, 6(12): 1114-1117.
[34]	Barss L, Sabur N, Orlikow E, et al. Diabetes Mellitus in adult patients with active tuberculosis in Canada: presentation and treatment outcomes[J]. Canadian Journal of Respiratory, Critical Care and Sleep Medicine, 2019, 3(2): 84-90. DOI: 10.1080/24745332.2018.1507615.
[35]	梁少碧.肺结核合并糖尿病与单纯肺结核治疗效果对比分析[J].中国医药科学, 2012, 2(13): 168-169. Liang SB. A comparative analysis of the therapeutic effect of tuberculosis combined with diabetes mellitus and simple tuberculosis[J]. China Med Pharm, 2012, 2(13): 168-169.
[36]	赵艳民. 216例2型糖尿病合并肺结核患者的临床治疗研究[J].中国实用医药, 2013, 8(16): 110-111. DOI: 10.14163/j.cnki.11-5547/r.2013.16.078. Zhao YM. Clinical treatment on 216 patients with type 2 diabetes mellitus and pulmonary tuberculosis[J]. China Prac Med, 2013, 8(16): 110-111. DOI: 10.14163/j.cnki.11-5547/r.2013.16.078.
[37]	Mi F, Tan S, Liang L, et al. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China[J]. Trop Med Int Health, 2013, 18(11): 1379-1385. DOI: 10.1111/tmi.12198.
[38]	Park SW, Shin JW, Kim JY, et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(7): 1305-1310. DOI: 10.1007/s10096-011-1443-3.
[39]	Degner NR, Wang JY, Golub JE, et al. Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment[J]. Clin Infect Dis, 2018, 66(2): 198-205. DOI: 10.1093/cid/cix819.
[40]	向娟, 肖谦.糖尿病:结核病的高危因素[J].新医学, 2010, 41(3): 200-201. Xiang J, Xiao Q. Diabetes: a high risk factor for tuberculosis[J]. J New Med, 2010, 41(3): 200-201.
[41]	Fisher-Hoch SP, Whitney E, McCormick JB, et al. Type 2 diabetes and multidrug-resistant tuberculosis[J]. Scand J Infect Dis, 2008, 40(11-12): 888-893. DOI: 10.1080/00365540802342372.
[42]	Baghaei P, Tabarsi P, Javanmard P, et al. Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis[J]. J Glob Antimicrob Resist, 2016, 4: 1-4. DOI: 10.1016/j.jgar.2015.11.006.
[43]	Magee MJ, Bloss E, Shin SS, et al. Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru[J]. Int J Infect Dis, 2013, 17(6): 404-412. DOI: 10.1016/j.ijid.2012.12.029.
[44]	Boillat-Blanco N, Ramaiya KL, Mganga M, et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms[J]. J Infect Dis, 2016, 213(7): 1163-1172. DOI: 10.1093/infdis/jiv568.
[45]	Moreira J, Castro R, Lamas C, et al. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil[J]. Int J Infect Dis, 2018, 69: 11-19. DOI: 10.1016/j.ijid.2017.12.014.
[46]	Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes[J]. Tuberculosis, 2017, 103: 83-91. DOI: 10.1016/j.tube.2017.01.006.
[47]	曹松玉, 王蓓.我国肺结核病患者结核病健康教育干预效果的Meta分析[J].中华疾病控制杂志, 2011, 15(2): 119-122. Cao SY, Wang B. Meta-analysis of effect of tuberculosis health education on patients with tuberculosis in China[J]. Chin J Dis Control Prev, 2011, 15(2): 119-122.
[48]	李丽.结核病合并糖尿病免疫特征研究进展[J].中华微生物学和免疫学杂志, 2016, 36(7): 549-554. DOI: 10.3760/cma.j.issn.0254-5101.2016.07.014. Li L. Advances in immune characteristics of tuberculosis patients complicated with diabetes mellitus[J]. Chin J Microbiol Immunol, 2016, 36(7): 549-554. DOI: 10.3760/cma.j.issn.0254-5101.2016.07.014.
[49]	刘日辉, 李卓林, 姚燕, 等.肺结核患者并发糖尿病的影响因素研究[J].中华疾病控制杂志, 2013, 17(8): 684-686. Liu RH, Li ZL, Yao Y, et al. Study on influencing factors of pulmonary tuberculosis patients complicated with diabetes mellitus[J]. Chin J Dis Control Prev, 2013, 17(8): 684-686.
[50]	周利君, 卢水华, 李亮.糖尿病并发肺结核发病机制的研究进展[J].中华传染病杂志, 2013, 31(9): 568-570. DOI: 10.3760/cma.j.issn.1000-6680.2013.09.015. Zhou LJ, Lu SH, Li L. Advances in research on the pathogenesis of diabetes complicated with pulmonary tuberculosis[J]. Chin J Infect Dis, 2013, 31(9): 568-570. DOI: 10.3760/cma.j.issn.1000-6680.2013.09.015.
[51]	Grotzke JE, Lewinsohn DM. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection[J]. Microbes Infect, 2005, 7(4): 776-788. DOI: 10.1016/j.micinf.2005.03.001.
[52]	Sun Q, Zhang Q, Xiao H, et al. Significance of the frequency of CD4+CD25+CD127-T-cells in patients with pulmonary tuberculosis and diabetes mellitus[J]. Respirology, 2012, 17(5): 876-882. DOI: 10.1111/j.1440-1843.2012.02184.x.
[53]	Kumar Nathella P, Babu S. Influence of diabetes mellitus on the immunity to human tuberculosis[J]. Immunology, 2017, 152(1): 13-24. DOI: 10.1111/imm.12762.
[54]	Stalenhoef JE, Alisjahbana B, Nelwan EJ, et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus[J]. Eur J Clin Microbiol Infect Dis, 2008, 27(2): 97-103. DOI: 10.1007/s10096-007-0395-0.
[55]	Gonzalez-Curiel I, Castaneda-Delgado J, Lopez-Lopez N, et al. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus[J]. Hum Immunol, 2011, 72(8): 656-662. DOI: 10.1016/j.humimm.2011.03.027.
[56]	Hodgson K, Morris J, Bridson T, et al. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections[J]. Immunology, 2015, 144(2): 171-185. DOI: 10.1111/imm.12394.
[57]	Sekhar RV, Mckay SV, Patel SG, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine[J]. Diabetes Care, 2011, 34(1): 162-167. DOI: 10.2337/dc10-1006.
[58]	Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy[J]. Nat Med, 2009, 15(8): 921-929. DOI: 10.1038/nm.2001.